Skip to main content
    S

    Scilex Holding Company (SCLX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $1.25
    -0.18 (-12.59%)

    Market Cap: $10.06M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Scilex Holding Company (SCLX) Financials: Revenue, Profit and Cash Flow

    Updated Aug 14, 2026. Financial statements from company filings, amounts in US dollars.

    Scilex Holding Company reported revenue of $30.25M for the fiscal year ended Dec 31, 2025, down 46.5% from the year before. That year, net income was -$374.05M with a net margin of -1236.4%, operating cash flow was $3.82M and free cash flow was $2.68M. The quarter ended Jun 30, 2026 had revenue of $7.64M and net income of -$229.97M.

    Revenue and Margins

    Over the 6 years to Dec 2025, revenue grew from $21.03M, a compound annual rate of 6.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$30.25M-46.5%65.0%-1143.7%-1236.4%
    Dec 2024$56.59M+21.1%70.5%-147.4%-128.7%
    Dec 2023$46.74M+22.9%66.5%-225.6%-244.6%
    Dec 2022$38.03M+21.4%71.6%-133.1%-61.4%
    Dec 2021$31.32M+32.9%88.4%-114.4%-282.4%
    Dec 2020$23.56M+12.0%90.9%-149.7%-201.7%
    Dec 2019$21.03MN/A72.4%-659.4%-849.1%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$30.25M$56.59M$46.74M$38.03M$31.32M$23.56M$21.03M
    Cost of revenue$10.60M$16.69M$15.68M$10.80M$3.63M$2.15M$5.80M
    Gross profit$19.65M$39.90M$31.06M$27.24M$27.68M$21.41M$15.23M
    Research and development$20.71M$9.64M$12.75M$9.05M$9.20M$9.96M$85.52M
    Operating income-$346.01M-$83.40M-$105.43M-$50.63M-$35.84M-$35.26M-$138.69M
    Net income-$374.05M-$72.81M-$114.33M-$23.36M-$88.42M-$47.52M-$178.59M
    EBITDAN/A-$66.48MN/A-$35.29MN/A-$20.02MN/A
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$7.64M$8.61M$4.79M$10.56M$9.90M$5.00M$14.90M$14.44M$16.37M$10.88M$13.46M$10.12M
    Gross profit$3.96M$4.17M$2.18M$7.23M$6.62M$3.62M$10.21M$10.67M$11.98M$7.04M$8.94M$6.72M
    Operating income-$29.42M-$32.17M-$111.09M-$186.51M-$20.51M-$27.90M-$28.38M-$19.92M-$15.62M-$19.48M-$18.34M-$38.80M
    Net income-$229.97M-$45.65M-$46.10M-$257.82M-$88.10M-$26.08M-$6.46M-$4.39M-$37.58M-$24.38M-$21.40M-$35.53M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $105.74M exceeded cash and equivalents by $100.79M. Shareholder equity was negative, at -$207.78M, as total liabilities of $576.73M exceeded total assets of $364.98M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$364.98M$92.95M$101.31M$86.53M$77.93M$199.48KN/A
    Current assets$38.36M$41.55M$46.78M$29.61M$23.00M$30.51KN/A
    Cash and equivalents$4.96M$3.27M$3.92M$2.18M$4.34M$30.51KN/A
    Total liabilities$576.73M$285.59M$274.25M$50.29M$301.81M$180.76KN/A
    Short-term debt$83.26M$34.88M$108.43M$0$57.56M$125.00KN/A
    Long-term debt$22.48M$845.00K$17.04M$0$95.54M$107.66MN/A
    Shareholder equity-$207.78M-$192.64M-$172.94M$36.24M-$223.88M$18.72KN/A
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$253.56M$293.63M$364.98M$275.88M$83.75M$78.98M$92.95M$100.43M$104.54M$91.24M$101.31M$80.53M
    Total liabilities$564.05M$547.71M$576.73M$455.60M$332.74M$290.46M$285.59M$311.75M$319.24M$281.03M$274.25M$243.20M
    Cash and equivalents$566.00K$3.35M$4.96M$878.00K$4.10M$5.80M$3.27M$77.00K$6.89M$1.82M$3.92M$1.95M
    Shareholder equity-$308.32M-$249.22M-$207.78M-$176.94M-$248.99M-$211.48M-$192.64M-$211.32M-$214.69M-$189.79M-$172.94M-$162.67M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 70.2% of operating cash flow. Share repurchases came to 1072.8% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow$3.82M$19.35M-$20.71M-$21.26M-$28.66M-$31.46M-$60.42M
    Capital expenditures$1.13M$0$30.00K$7.00K$0$25.00K$584.00K
    Free cash flow$2.68M$19.35M-$20.74M-$21.27M-$28.66M-$31.49M-$61.01M
    Dividends paidN/AN/A$10.00MN/AN/AN/AN/A
    Share repurchases$28.75M$0$0N/AN/AN/AN/A
    Investing cash flow$4.08M-$2.67M-$330.00K-$2.07M$0-$25.00K-$17.62M
    Financing cash flow-$5.46M-$18.13M$23.58M$21.17M$28.16M-$19.17M$15.78M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$6.74M-$1.11M-$17.47M$8.23M$7.05M$6.01M$2.53M$5.11M$2.31M$9.39M-$5.39M$5.90M
    Capital expendituresN/A$3.05M$83.00K$300.00KN/A$150.00K$150.00K$150.00K$150.00K$150.00K$1.00K$21.00K
    Free cash flowN/A-$4.16M-$17.55M$7.93MN/A$5.86M$2.38M$4.96M$2.16M$9.24M-$5.39M$5.88M
    Last 12 quarters

    Frequently Asked Questions About SCLX

    What is Scilex Holding Company's annual revenue?

    Scilex Holding Company reported revenue of $30.25M for the fiscal year ended Dec 31, 2025.

    How fast is Scilex Holding Company's revenue growing?

    Revenue was down 46.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -7.3%.

    Is Scilex Holding Company profitable?

    No. Scilex Holding Company reported net income of -$374.05M for the fiscal year ended Dec 31, 2025, with a net margin of -1236.4%.

    How much free cash flow does SCLX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $3.82M minus capital expenditures of $1.13M produced free cash flow of $2.68M.

    How much debt does Scilex Holding Company have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $22.48M, short-term debt of $83.26M and cash and equivalents of $4.96M.